James Delmez
Overview
Explore the profile of James Delmez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ritter C, Zhang S, Delmez J, Finch J, Slatopolsky E
Kidney Int
. 2015 Feb;
87(6):1141-52.
PMID: 25692955
Klotho plays an important role in the pathogenesis of cardiovascular disease in chronic kidney disease (CKD). Klotho is highly expressed in the kidney and parathyroid glands, but its presence in...
2.
Ritter C, Zhang S, Finch J, Liapis H, Suarez E, Ferder L, et al.
Kidney Blood Press Res
. 2014 Oct;
39(4):340-52.
PMID: 25300759
Background/aims: The search for new therapies providing cardiorenal protection in chronic kidney disease (CKD) has led to treatments that combine conventional renin-angiotensin-aldosterone-system inhibitors with other drugs that exhibit potential in...
3.
Fishbane S, Delmez J, Suki W, Hariachar S, Heaton J, Chasan-Taber S, et al.
Am J Kidney Dis
. 2010 Jan;
55(2):307-15.
PMID: 20042256
Background: Sevelamer carbonate powder for oral suspension is a new dosage form of sevelamer, which may be suited to once-daily dosing. Study Design: Randomized parallel open-label study. Setting & Participants:...
4.
Zheng S, de las Fuentes L, Bierhals A, Ash-Bernal R, Spence K, Slatopolsky E, et al.
Am J Cardiol
. 2008 Dec;
103(1):46-9.
PMID: 19101228
Vascular calcium deposition in end-stage renal disease occurs commonly, but its relation to cardiovascular risk factors and fetuin-A levels in African Americans is not known. Compliant African American patients who...
5.
Cheung A, Greene T, Leypoldt J, Yan G, Allon M, Delmez J, et al.
Clin J Am Soc Nephrol
. 2007 Dec;
3(1):69-77.
PMID: 18057309
Background And Objectives: Secondary analysis of the Hemodialysis Study showed that serum beta(2)-microglobulin levels predicted all-cause mortality and that high-flux dialysis was associated with decreased cardiac deaths in hemodialysis patients....
6.
Greene T, Daugirdas J, Depner T, Allon M, Beck G, Chumlea C, et al.
J Am Soc Nephrol
. 2005 Sep;
16(11):3371-80.
PMID: 16192421
In the intention-to-treat analysis of the Hemodialysis Study, all-cause mortality did not differ significantly between the high versus standard hemodialysis dose groups. The association of mortality with delivered dose within...
7.
Depner T, Daugirdas J, Greene T, Allon M, Beck G, Chumlea C, et al.
Kidney Int
. 2004 Apr;
65(4):1386-94.
PMID: 15086479
Background: Gender and body size have been associated with survival in hemodialysis populations. In recent observational studies, overall mortality was similar in men and women and higher in small patients....